Retrospective Study
Copyright ©The Author(s) 2016.
World J Nephrol. Jul 6, 2016; 5(4): 367-371
Published online Jul 6, 2016. doi: 10.5527/wjn.v5.i4.367
Table 1 Patients on presenting with lactic acidosis and sepsis
All patientsPatients on metformin
No. of patients327
Age (yr)122-8546-81
Sex19 females4 female
Ethnicity19 Europeans,3 Europeans,
9 Pacific People,3 Pacific People
1 NZ Maori,
1 Indian
2 Chinese
Baseline Creatinine (μmol/L)41-20058-140
2eGFR mL/min per 1.73 m225-9031-87
Creatinine at presentation (μmol/L)50-600103-463
Number who died153
Number receiving acute haemodialysisThreeNil
Creatinine at discharge (μmol/L)53-24556-60
eGFR mL Tab/min per 1.73 m222-9077-90
Table 2 Demographic and clinical details of patients with metformin associated lactic acidosis
Patients12345678910
Age (yr)168536863804083556772
SexMaleMaleMaleFemaleMaleFemaleFemaleFemaleFemaleFemale
EthnicityPacific IslanderIndianEuropeanPacific IslanderPacific IslanderPacific IslanderPacific IslanderPacific IslanderEuropeanEuropean
Metformin dose (g/d)2.51.72322121.71
Duration of Metformin25 yr4 yr5 yr4 yr2 yr1 yr4 yr4 yr4 yr2 mo
Baseline Creatinine (μmol/L)11457138123106123180105154139
3eGFR mL/min per 1.73 m2551304438584223472932
Creatinine at Presentation (μmol/L)44990333612381612376895973304
pH7.37.237.147.326.997.217.346.97.357.09
Bicarbonate (mmol/L)151313166121231515
Lactate (mmol/L)9.26.7156168.46226.27
Received acute haemodialysisYesNoYesNoNoNoNoNoYesNo
OutcomeDeadAliveAliveAliveDeadAliveAliveAliveAliveAlive
Creatinine at discharge (μmol/L)-7312195-9016712312996
3eGFR mL/min per 1.73 m2-975252-6025393650